Extracellular but not cytosolic superoxide dismutase protects against oxidant-mediated endothelial dysfunction

Redox Biology

Volumn 1, Issue 1, 2013, Pages 292-296

  Foresman, Erin L ^a   Miller, Francis J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Endothelial dysfunction; Gene transfer; Oxygen free radicals; Superoxide dismutase

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; COPPER ZINC SUPEROXIDE DISMUTASE; EXTRACELLULAR SUPEROXIDE DISMUTASE; NITROPRUSSIDE SODIUM; OXYGEN; PHENYLEPHRINE; SUPEROXIDE DISMUTASE; XANTHINE; XANTHINE OXIDASE; NITRIC OXIDE; OXIDIZING AGENT; PROTECTIVE AGENT; SUPEROXIDE;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; HISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RABBIT; SMOOTH MUSCLE RELAXATION; VASCULAR RING; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CYTOLOGY; DEPENDOPARVOVIRUS; DRUG EFFECTS; GENE VECTOR; GENETICS; METABOLISM; VASCULAR ENDOTHELIUM; VIROLOGY;

ADENOVIRIDAE; ESCHERICHIA COLI; ORYCTOLAGUS CUNICULUS;

ADVENTITIA; ANIMALS; AORTA; DEPENDOVIRUS; ENDOTHELIUM, VASCULAR; GENETIC VECTORS; MALE; NITRIC OXIDE; OXIDANTS; PHENYLEPHRINE; PROTECTIVE AGENTS; RABBITS; SUPEROXIDE DISMUTASE; SUPEROXIDES; XANTHINE; XANTHINE OXIDASE;

EID: 84879434661     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2013.04.003     Document Type: Article

References (34)

1. White C.R., Parks D.A., Patel R.P., Shelton J., Tarpey M.M., Freeman B.A., Darley-Usmar V.M. L-Arginine inhibits xanthine oxidase-dependent endothelial dysfunction in hypercholesterolemia. FEBS Letters 2004, 561:94-98.
2. White C.R., Darley-Usmar V., Berrington W.R., McAdams M., Gore J.Z., Thompson J.A., Parks D.A., Tarpey M.M., Freeman B.A. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proceedings of the National Academy of Sciences of USA 1996, 93:8745-8749.
3. Swain J., Gutteridge J.M. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material. FEBS Letters 1995, 368:513-515.
4. Spiekermann S., Landmesser U., Dikalov S., Bredt M., Gamez G., Tatge H., Reepschlager N., Hornig B., Drexler H., Harrison D.G. Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 2003, 107:1383-1389.
5. Guzik T.J., Sadowski J., Guzik B., Jopek A., Kapelak B., Przybylowski P., Wierzbicki K., Korbut R., Harrison D.G., Channon K.M. Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2006, 26:333-339.
6. Higgins P., Dawson J., Lees K.R., McArthur K., Quinn T.J., Walters M.R. Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis. Cardiovascular Therapy 2012, 30:217-226.
7. Gryglewsli R.J., Palmer R.M.J., Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986, 320:454-456.
8. White C.R., Brock T.A., Chang L., Crapo J., Briscoe P., Ku D., Bradley W.A., Gianturco S.H., Gore J., Freeman B.A., Tarpey M.M. Superoxide and peroxynitrite in atherosclerosis. Proceedings of the National Academy of Sciences of USA 1994, 91:1044-1048.
9. Zmijewski J.W., Landar A., Watanabe N., Dickinson D.A., Noguchi N., Darley-Usmar V.M. Cell signalling by oxidized lipids and the role of reactive oxygen species in the endothelium. Biochemical Society Transactions 2005, 33:1385-1389.
10. Ikeda H., Koga Y., Oda T., Kuwano K., Nakayama H., Ueno T., Toshima H., Michael L.H., Entman M.L. Free oxygen radicals contribute to platelet aggregation and cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. Journal of the American College og Cardiology 1994, 24:1749-1756.
11. Rattan V., Sultana C., Shen Y., Kalra V.K. Oxidant stress-induced transendothelial migration of monocytes is linked to phosphorylation of PECAM-1. American Journal of Physiology 1997, 273:E453-E461.
12. Li P.F., Dietz R., von Harsdorf R. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 1997, 96:3602-3609.
13. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. Journal of Clinical Investigations 1996, 97:1916-1923.
14. Heistad D.D. Oxidative stress and vascular disease: 2005 Duff lecture. Arteriosclerosis, Thrombosis, and Vascular Biology 2006, 26:689-695.
15. Fukai T., Folz R.J., Landmesser U., Harrison D.G. Extracellular superoxide dismutase and cardiovascular disease. Cardiovascular Research 2002, 55:239-249.
16. Lund D.D., Gunnett C.A., Chu Y., Brooks R.M., Faraci F.M., Heistad D.D. Gene transfer of extracellular superoxide dismutase improves relaxation of aorta after treatment with endotoxin. American Journal of Physiology-Heart and Circulatory Physiology 2004, 287:H805-811.
17. Chu Y., Iida S., Lund D.D., Weiss R.M., DiBona G.F., Watanabe Y., Faraci F.M., Heistad D.D. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circulatory Research 2003, 92:461-468.
18. Levonen A.L., Vahakangas E., Koponen J.K., Yla-Herttuala S. Antioxidant gene therapy for cardiovascular disease: current status and future perspectives. Circulation 2008, 117:2142-2150.
19. Qin Z., Reszka K.J., Fukai T., Weintraub N.L. Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD. Translational Research 2008, 151:68-78.
20. Zanetti M., Sato J., Katusic Z.S., O'Brien T. Gene transfer of superoxide dismutase isoforms reverses endothelial dysfunction in diabetic rabbit aorta. American Journal of Physiology-Heart and Circulatory Physiology 2001, 280:H2516-2523.
21. Miller F.J., Gutterman D.D., Rios C.D., Heistad D.D., Davidson B.L. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circulatory Research 1998, 82:1298-1305.
22. Nakane H., Miller F.J., Faraci F.M., Toyoda K., Heistad D.D. Gene transfer of endothelial nitric oxide synthase reduces angiotensin II-induced endothelial dysfunction. Hypertension 2000, 35:595-601.
23. Zwacka R.M., Epperly M.W., Greenberger J.L., Engelhardt J.F. Redox gene therapy protects human IB-3 lung epithelial cells against ionizing radiation-induced apoptosis. Human Gene Therapy 1998, 9:1381-1386.
24. Paoletti F., Mocali A. Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. Methods in Enzymology 1990, 186:209-220.
25. Chu Y., Alwahdani A., Iida S., Lund D.D., Faraci F.M., Heistad D.D. Vascular effects of the human extracellular superoxide dismutase R213G variant. Circulation 2005, 112:1047-1053.
26. Weydert C.J., Cullen J.J. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nature Protocols 2010, 5:51-66.
27. Dowell F.J., Hamilton C.A., McMurray J., Reid J.L. Effects of a xanthine oxidase/hypoxanthine free radical and reactive oxygen species generating system on endothelial function in New Zealand white rabbit aortic rings. Journal of Cardiovascular Pharmacology 1993, 22:792-979.
28. Tan S., Yokoyama Y., Dickens E., Cash T.G., Freeman B.A., Parks D.A. Xanthine oxidase activity in the circulation of rats following hemorrhagic shock. Free Radical Biology and Medicine 1993, 15:407-414.
29. Houston M., Estevez A., Chumley P., Aslan M., Marklund S., Parks D.A., Freeman B.A. Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. Journal of Biological Chemistry 1999, 274:4985-4994.
30. Chu Y., Piper R., Richardson S., Watanabe Y., Patel P., Heistad D.D. Endocytosis of extracellular superoxide dismutase into endothelial cells: role of the heparin-binding domain. Arteriosclerosis, Thrombosis, and Vascular Biology 2006, 26:1985-1990.
31. Terada L.S., Guidot D.M., Leff J.A., Willingham I.R., Hanley M.E., Piermattei D., Repine J.E. Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proceedings of the National Academy of Sciences of USA 1992, 89:3362-3366.
32. Lee B.E., Toledo A.H., Anaya-Prado R., Roach R.R., Toledo-Pereyra L.H. Allopurinol xanthine oxidase, and cardiac ischemia. Journal of Investigative Medicine 2009, 57:902-909.
33. Gunnett C.A., Heistad D.D., Faraci F.M. Interleukin-10 protects nitric oxide-dependent relaxation during diabetes: role of superoxide. Diabetes 2002, 51:1931-1937.
34. Doehner W., Landmesser U. Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options. Seminars in Nephrology 2011, 31:433-440.